Friday, April 28, 2017 11:14:22 PM
Can you link specifically to the prospectus you are referring to? But...
Look at the people involved in NMUS
Look at how the company has been run
Look at their candidates and IP
This is insanely undervalued compared to peers and Tier 1 cannibinoid companies.
Because of how poorly the RTO went and NMUS stock price, and the fact that it was a RTO, might prevent them from getting the financing they need to get the Phase 1 and 2 trials.
Or, they could get the money, but its Death spiral PiPE and it deludes the Crap out of our holdings.
Were serious Adults here on the NMUS board. I like my side of the bet.
GLTFA
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM